All Stories

  1. Automated CD34+ cell isolation of peripheral blood stem cell apheresis product

    Article • Cytotherapy, October 2015, Elsevier

    Dr Halvard B Bonig

  2. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus

    Article • Cytotherapy, August 2015, Elsevier

    Dr Halvard B Bonig

  3. Optimization and validation of processes related to the GMP compliant manufacture of genetically modified CAR expressing NK-92 cells

    Article • Cytotherapy, June 2015, Elsevier

    Dr Halvard B Bonig

  4. Establishment of a GMP-compliant mesenchymal stromal cell bank from pooled bone marrow mononuclear cells of eight “third-party” healthy donors: clinical evidence of safety and efficacy

    Article • Cytotherapy, June 2015, Elsevier

    Dr Halvard B Bonig

  5. Concise Review: CXCR4/CXCL12 Signaling in Immature Hematopoiesis-Lessons From Pharmacological and Genetic Models

    Article • Stem Cells, May 2015, Wiley

    Dr Halvard B Bonig

  6. Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer

    Article • Clinical Cancer Research, May 2015, American Association for Cancer Research (AACR)

    Dr Halvard B Bonig

  7. Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise

    Article • Vox Sanguinis, May 2015, Wiley

    Dr Halvard B Bonig

  8. Cell-Based Therapy by Implanted Human Bone Marrow-Derived Mononuclear Cells Improved Bone Healing of Large Bone Defects in Rats

    Article • Tissue Engineering Part A, May 2015, Mary Ann Liebert Inc

    Dr Halvard B Bonig

  9. Discovery and Characterization of an Endogenous CXCR4 Antagonist

    Article • Cell Reports, May 2015, Elsevier

    Dr Halvard B Bonig, Prof Guillermo Gimenez-Gallego

  10. RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation

    Article • Blood, April 2015, American Society of Hematology

    Dr Halvard B Bonig

  11. Variant rs1801157 in the 3’UTR of SDF-1ß Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness

    Article • PLoS ONE, March 2015, PLOS

    Dr Halvard B Bonig

  12. Functional Consequences of Perturbed CXCL12 Signal Processing: Analyses of Immature Hematopoiesis in GRK6-Deficient Mice

    Article • Stem Cells and Development, March 2015, Mary Ann Liebert Inc

    Dr Halvard B Bonig

  13. CD105 Is a Surface Marker for Receptor-Targeted Gene Transfer into Human Long-Term Repopulating Hematopoietic Stem Cells

    Article • Stem Cells and Development, March 2015, Mary Ann Liebert Inc

    Dr Halvard B Bonig

  14. NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells

    Article • Leukemia, February 2015, Springer Science + Business Media

    Dr Halvard B Bonig

  15. Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies

    Article • Transfusion, February 2015, Wiley

    Dr Halvard B Bonig

  16. Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

    Article • Molecular Therapy, February 2015, Elsevier

    Dr Halvard B Bonig

  17. Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications

    Article • Cytotherapy, February 2015, Elsevier

    Dr Halvard B Bonig

  18. Dopaminergic Modulation of Cognitive Preparation for Overt Reading: Evidence from the Study of Genetic Polymorphisms

    Article • Cerebral Cortex, January 2015, Oxford University Press (OUP)

    Dr Halvard B Bonig

  19. Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue EngineeringIn Vitro

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Halvard B Bonig

  20. VLA4 in Acute Lymphoblastic Leukemia

    Article • November 2014, Springer Science + Business Media

    Dr Halvard B Bonig

  21. Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34+ cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers

    Article • Cytotherapy, November 2014, Elsevier

    Dr Halvard B Bonig

  22. In reply

    Article • Transfusion, October 2014, Wiley

    Dr Halvard B Bonig

  23. The Challenges of Autologous Cell Therapy: Systemic Anti-thrombotic Therapies Interfering with Serum Coagulation May Disable Autologous Serum-Containing Cell Products for Therapeutical Use

    Article • Journal of Cardiovascular Translational Research, September 2014, Springer Science + Business Media

    Dr Halvard B Bonig

  24. A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testing

    Article • Cell and Tissue Banking, September 2014, Springer Science + Business Media

    Dr Halvard B Bonig

  25. Clinical-scale isolation of ‘minimally manipulated’ cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease

    Article • Cytotherapy, September 2014, Elsevier

    Dr Halvard B Bonig

  26. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation

    Article • Bone Marrow Transplantation, August 2014, Springer Science + Business Media

    Dr Halvard B Bonig

  27. ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA

    Article • Neuro-Oncology, July 2014, Oxford University Press (OUP)

    Dr Halvard B Bonig

  28. Biosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?

    Article • Transfusion, June 2014, Wiley

    Dr Halvard B Bonig

  29. Faculty of 1000 evaluation for Fgd5 identifies hematopoietic stem cells in the murine bone marrow.

    Article • June 2014, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  30. Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells

    Article • Leukemia, June 2014, Springer Science + Business Media

    Dr Halvard B Bonig

  31. Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion

    Article • Cytotherapy, June 2014, Elsevier

    Dr Halvard B Bonig

  32. PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation

    Article • Nature Communications, May 2014, Springer Science + Business Media

    Dr Halvard B Bonig

  33. Role of Integrin Alpha4 in Drug Resistance of Leukemia

    Article • Frontiers in Oncology, May 2014, Frontiers

    Dr Halvard B Bonig

  34. Smac mimetic and glucocorticoids synergize to induce apoptosis in childhood ALL by promoting ripoptosome assembly

    Article • Blood, May 2014, American Society of Hematology

    Dr Halvard B Bonig, Dr. Andreas Weigert

  35. Faculty of 1000 evaluation for Asymmetry in skeletal distribution of mouse hematopoietic stem cell clones and their equilibration by mobilizing cytokines.

    Article • May 2014, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  36. Generation of aspergillus fumigatus-specific TH1 cells against invasive aspergillosis

    Article • Cytotherapy, April 2014, Elsevier

    Dr Halvard B Bonig

  37. Generation and qualification of a GMP compliant master cell stock of CAR expressing ErbB2-specific NK-92 cells for clinical trials

    Article • Cytotherapy, April 2014, Elsevier

    Dr Halvard B Bonig

  38. Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems

    Article • Transfusion, December 2013, Wiley

    Dr Halvard B Bonig

  39. Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates

    Article • Bone Marrow Transplantation, November 2013, Springer Science + Business Media

    Dr Halvard B Bonig

  40. Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers

    Article • PLoS ONE, September 2013, PLOS

    Dr Halvard B Bonig

  41. Faculty of 1000 evaluation for Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review.

    Article • September 2013, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  42. The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

    Article • Leukemia, September 2013, Springer Science + Business Media

    Dr Halvard B Bonig

  43. Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression

    Article • Haematologica, August 2013, Ferrata Storti Foundation (Haematologica)

    Dr Halvard B Bonig

  44. Mobilisierung hämatopoietischer Stammzellen

    Article • Transfusionsmedizin, August 2013, Thieme Publishing Group

    Dr Halvard B Bonig

  45. Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells

    Article • Clinical & Experimental Immunology, July 2013, Wiley

    Dr Halvard B Bonig

  46. Faculty of 1000 evaluation for CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.

    Article • June 2013, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  47. Faculty of 1000 evaluation for Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches.

    Article • June 2013, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  48. Granulocyte collections: comparison of two apheresis systems

    Article • Transfusion, April 2013, Wiley

    Dr Halvard B Bonig

  49. Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation

    Article • Bone Marrow Transplantation, March 2013, Springer Science + Business Media

    Dr Halvard B Bonig

  50. Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes

    Article • Cytotherapy, March 2013, Elsevier

    Dr Halvard B Bonig

  51. Leucodepletion for hyperleucocytosis - first report on a novel technology featuring electronic interphase management

    Article • Vox Sanguinis, February 2013, Wiley

    Dr Halvard B Bonig

  52. Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy

    Article • Blood, January 2013, American Society of Hematology

    Dr Halvard B Bonig

  53. Donor selection and release criteria of cellular therapy products

    Article • Vox Sanguinis, December 2012, Wiley

    Dr Halvard B Bonig

  54. Faculty of 1000 evaluation for Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance.

    Article • December 2012, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  55. Faculty of 1000 evaluation for Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model.

    Article • December 2012, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  56. Hematopoietic stem cell mobilization: updated conceptual renditions

    Article • Leukemia, September 2012, Springer Science + Business Media

    Dr Halvard B Bonig

  57. Pediatric apheresis with a novel apheresis device with electronic interface control

    Article • Transfusion, August 2012, Wiley

    Dr Halvard B Bonig

  58. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study

    Article • Vox Sanguinis, July 2012, Wiley

    Dr Halvard B Bonig

  59. Sufficient blood, safe blood: can we have both?

    Article • BMC Medicine, March 2012, Springer Science + Business Media

    Dr Halvard B Bonig

  60. Epigenetic Modifications and Chromosome Conformations of the Beta Globin Locus throughout Development

    Article • Stem Cell Reviews and Reports, February 2012, Springer Science + Business Media

    Dr Halvard B Bonig

  61. Faculty of 1000 evaluation for Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.

    Article • February 2012, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  62. Intracoronary bone marrow cell application for terminal heart failure in children

    Article • Cardiology in the Young, February 2012, Cambridge University Press

    Dr Halvard B Bonig

  63. Mobilization of Hematopoietic Stem/Progenitor Cells: General Principles and Molecular Mechanisms

    Article • January 2012, Springer Science + Business Media

    Dr Halvard B Bonig

  64. Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models

    Article • Frontiers in Oncology, January 2012, Frontiers

    Dr Halvard B Bonig

  65. Allogeneic donor peripheral blood “stem cell” apheresis: prospective comparison of two apheresis systems

    Article • Transfusion, November 2011, Wiley

    Dr Halvard B Bonig

  66. Mesenchymal stromal cells derived from CD271+ bone marrow mononuclear cells exert potent allosuppressive properties

    Article • Cytotherapy, November 2011, Elsevier

    Dr Halvard B Bonig

  67. Epigenetic Regulation of Endothelial Lineage Committed Genes in Pro-Angiogenic Hematopoietic and Endothelial Progenitor Cells

    Article • Circulation Research, October 2011, Wolters Kluwer Health

    Dr Halvard B Bonig

  68. Apheresis product identification in the transplant center: development of point-of-care protocols for extended blood typing of stem cell apheresis products

    Article • Bone Marrow Transplantation, September 2011, Springer Science + Business Media

    Dr Halvard B Bonig

  69. Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow)

    Article • Vox Sanguinis, September 2011, Wiley

    Dr Halvard B Bonig

  70. Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells

    Article • Best Practice & Research Clinical Haematology, September 2011, Elsevier

    Dr Halvard B Bonig

  71. Asystole during stem cell apheresis in a young healthy female volunteer donor

    Article • Transfusion, July 2011, Wiley

    Dr Halvard B Bonig

  72. Faculty of 1000 evaluation for Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplan...

    Article • July 2011, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  73. Potenzial hämatopoetischer Stammzellen als Ausgangsmaterial für Arzneimittel für neuartige Therapien

    Article • Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, June 2011, Springer Science + Business Media

    Dr Halvard B Bonig

  74. Erratum to: Validation of a rapid and inexpensive allele-specific amplification (ASA)-PCR genotyping assay for vitamin K antagonist pharmacogenomics

    Article • Molecular Diagnosis & Therapy, June 2011, Springer Science + Business Media

    Dr Halvard B Bonig

  75. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial

    Article • Vox Sanguinis, April 2011, Wiley

    Dr Halvard B Bonig

  76. Donor safety comes first

    Article • Vox Sanguinis, April 2011, Wiley

    Dr Halvard B Bonig

  77. Faculty of 1000 evaluation for Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice.

    Article • April 2011, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  78. Enumeration of viable CD34+ cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit

    Article • Cytotherapy, April 2011, Elsevier

    Dr Halvard B Bonig

  79. Validation of a Rapid and Inexpensive Allele-Specific Amplification (ASA)-PCR Genotyping Assay for Vitamin K Antagonist Pharmacogenomics

    Article • Molecular Diagnosis & Therapy, February 2011, Springer Science + Business Media

    Dr Halvard B Bonig

  80. Generation and Characterization of Erythroid Cells from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells: An Overview

    Article • Stem Cells International, January 2011, Hindawi Publishing Corporation

    Dr Halvard B Bonig

  81. Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device

    Article • Transfusion, December 2010, Wiley

    Dr Halvard B Bonig

  82. Vagrant Stem Cells Draft Their Gene Companions

    Article • Cell Stem Cell, November 2010, Elsevier

    Dr Halvard B Bonig

  83. Faculty of 1000 evaluation for In vivo cellular imaging pinpoints the role of reactive oxygen species in the early steps of adult hematopoietic reconstitution.

    Article • February 2010, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  84. Transplantation CD3/CD19-depletierter Stammzellen

    Article • Monatsschrift Kinderheilkunde, February 2010, Springer Science + Business Media

    Dr Halvard B Bonig

  85. On the adaptation of endosteal stem cell niche function in response to stress

    Article • Blood, September 2009, American Society of Hematology

    Dr Halvard B Bonig

  86. Faculty of 1000 evaluation for Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

    Article • August 2009, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  87. Blockade of α6-Integrin Reveals Diversity in Homing Patterns Among Human, Baboon, and Murine Cells

    Article • Stem Cells and Development, July 2009, Mary Ann Liebert Inc

    Dr Halvard B Bonig

  88. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100

    Article • Experimental Hematology, March 2009, Elsevier

    Dr Halvard B Bonig

  89. Accumulation of soluble inflammatory mediators between blood donation and pre-storage leucocyte depletion

    Article • Vox Sanguinis, February 2009, Wiley

    Dr Halvard B Bonig

  90. Faculty of 1000 evaluation for Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche.

    Article • January 2009, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  91. Faculty of 1000 evaluation for Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair.

    Article • January 2009, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  92. Concurrent Blockade of α4-Integrin and CXCR4 in Hematopoietic Stem/Progenitor Cell Mobilization

    Article • Stem Cells, January 2009, Wiley

    Dr Halvard B Bonig

  93. Faculty of 1000 evaluation for Biologic properties and enucleation of red blood cells from human embryonic stem cells.

    Article • September 2008, Faculty of 1000, Ltd.

    Dr Halvard B Bonig

  94. Blood types of current embryonic stem cell lines are not conducive to culturing "universal-donor" red blood cells

    Article • Transfusion, May 2008, Wiley

    Dr Halvard B Bonig

  95. Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab

    Article • Blood, April 2008, American Society of Hematology

    Dr Halvard B Bonig

  96. Response: More about multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors

    Article • Blood, February 2008, American Society of Hematology

    Dr Halvard B Bonig

  97. Hematopoietic Progenitor Cells (HPC) from Mobilized Peripheral Blood Display Enhanced Migration and Marrow Homing Compared to Steady-State Bone Marrow HPC

    Article • Experimental Hematology, February 2007, Elsevier

    Dr Halvard B Bonig

  98. The p67 laminin receptor identifies human erythroid progenitor and precursor cells and is functionally important for their bone marrow lodgment

    Article • Blood, August 2006, American Society of Hematology

    Dr Halvard B Bonig

  99. Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines

    Article • Blood, January 2006, American Society of Hematology

    Dr Halvard B Bonig

  100. Long-term functional impairment of hemopoietic progenitor cells engineered to express the S1 catalytic subunit of pertussis toxin

    Article • Experimental Hematology, June 2005, Elsevier

    Dr Halvard B Bonig

  101. PTX-sensitive signals in bone marrow homing of fetal and adult hematopoietic progenitor cells

    Article • Blood, June 2004, American Society of Hematology

    Dr Halvard B Bonig

  102. BILATERAL EXOPHTHALMUS DUE TO RETRO-ORBITAL CHLOROMAS IN A BOY WITH t(8;21)-POSITIVE ACUTE MYELOBLASTIC LEUKEMIA

    Article • Pediatric Hematology and Oncology, January 2002, Taylor & Francis

    Dr Halvard B Bonig

  103. ENDOGENOUS PRO-INFLAMMATORY CYTOKINES IN CHILDREN AND ADOLESCENTS DURING CHEMOTHERAPY-INDUCED NEUTROPENIA

    Article • Pediatric Hematology and Oncology, January 2002, Taylor & Francis

    Dr Halvard B Bonig

  104. Growth factors and hemostasis: differential effects of GM-CSF and G-CSF on coagulation activation – laboratory and clinical evidence

    Article • Annals of Hematology, August 2001, Springer Science + Business Media

    Dr Halvard B Bonig

  105. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF) – results of a prospective randomised monocentre study

    Article • Bone Marrow Transplantation, August 2001, Springer Science + Business Media

    Dr Halvard B Bonig

  106. Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma – a rationale for tailored supportive care

    Article • Supportive Care in Cancer, July 2001, Springer Science + Business Media

    Dr Halvard B Bonig

  107. CO-OPERATION OF IL-1 AND IL-2 ON T-CELL ACTIVATION IN MONONUCLEAR CELL CULTURES

    Article • Immunological Investigations, January 2001, Taylor & Francis

    Dr Halvard B Bonig

  108. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors

    Article • Bone Marrow Transplantation, July 2000, Springer Science + Business Media

    Dr Halvard B Bonig

  109. ‘Sepsis’ and multi-organ failure: predictors of poor outcome after hematopoietic stem cell transplantation in children

    Article • Bone Marrow Transplantation, May 2000, Springer Science + Business Media

    Dr Halvard B Bonig

  110. Regulation of Interleukin-2 Induced Interleukin-5 and Interleukin-13 Production in Human Peripheral Blood Mononuclear Cells

    Article • Scandinavian Journal of Immunology, January 2000, Wiley

    Dr Halvard B Bonig

  111. Monocyte deactivation and its reversal in a patient with chemotherapy-induced leukopenia and severe systemic infection

    Article • Medical and Pediatric Oncology, January 2000, Wiley

    Dr Halvard B Bonig

  112. Transforming Growth Factor-β1 Suppresses Interleukin-15-Mediated Interferon-γ Production in Human T Lymphocytes

    Article • Scandinavian Journal of Immunology, December 1999, Wiley

    Dr Halvard B Bonig

  113. Cytokine-Mediated Regulation of Granulocyte Colony-Stimulating Factor Production

    Article • Scandinavian Journal of Immunology, November 1999, Wiley

    Dr Halvard B Bonig

  114. Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation

    Article • Gut, November 1999, BMJ

    Dr Halvard B Bonig

  115. Additive effects of infection and neutropenia on the induction of granulocytopoietic activity in vivo

    Article • Cancer, July 1999, Wiley

    Dr Halvard B Bonig

  116. Additive effects of infection and neutropenia on the induction of granulocytopoietic activity in vivo

    Article • Cancer, July 1999, Wiley

    Dr Halvard B Bonig

  117. Role of Il10 and Il12 in Il2 Induced T-Cell Activation

    Article • Pediatric Research, May 1999, Springer Science + Business Media

    Dr Halvard B Bonig

  118. Interleukin 10 Inhibits TNF-Alpha Production in Human Monocytes Independently of Interleukin 12 and Interleukin 1 Beta

    Article • Immunological Investigations, January 1999, Taylor & Francis

    Dr Halvard B Bonig

  119. Release of the Soluble Interleukin-6 Receptor from Human T-Cells

    Article • Immunological Investigations, January 1998, Taylor & Francis

    Dr Halvard B Bonig

  120. Pediatric Hematology and Oncology at the Heinrich-Heine University Medical School, DÜSSELDORF, Germany

    Article • Pediatric Hematology and Oncology, January 1998, Taylor & Francis

    Dr Halvard B Bonig

  121. Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio-/chemotherapy and autologous stem cell transplantation

    Article • Infection, January 1998, Springer Science + Business Media

    Dr Halvard B Bonig

  122. Interaction Between Interleukin 10 and Interleukin 6 in Human B-Cell Differentiation

    Article • Immunological Investigations, January 1998, Taylor & Francis

    Dr Halvard B Bonig

  123. High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation

    Article • Bone Marrow Transplantation, September 1997, Springer Science + Business Media

    Dr Halvard B Bonig

  124. Decreased interleukin 10 and increased interferon-γ production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation

    Article • Bone Marrow Transplantation, April 1997, Springer Science + Business Media

    Dr Halvard B Bonig

  125. Interleukin 10 Induced C-FOS Expression in Human B Cells by Activation of Divergent Protein Kinases

    Article • Immunological Investigations, January 1996, Taylor & Francis

    Dr Halvard B Bonig

  126. Interleukin-10 Directly Inhibits the Interleukin-6 Production in T-Cells

    Article • Scandinavian Journal of Immunology, May 1995, Wiley

    Dr Halvard B Bonig